Prior Heart Failure Hospitalization, Clinical Outcomes, and Response to Sacubitril/Valsartan Compared with Valsartan in HFpEF

BACKGROUND: The period shortly after hospitalization for heart failure (HF) represents a high-risk window for recurrent clinical events, including rehospitalization or death. OBJECTIVES: To determine whether the efficacy and safety of sacubitril/valsartan varies in relation to the proximity to HF ho...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:J Am Coll Cardiol
Asıl Yazarlar: Vaduganathan, Muthiah, Claggett, Brian L., Desai, Akshay S., Anker, Stefan D., Perrone, Sergio V., Janssens, Stefan, Milicic, Davor, Arango, Juan L., Packer, Milton, Shi, Victor C., Lefkowitz, Martin P., McMurray, John J.V., Solomon, Scott D.
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: 2019
Konular:
Article
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC7983315/
https://ncbi.nlm.nih.gov/pubmed/31726194
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.jacc.2019.11.003
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller